NFE2L2 and neoplasm: Also GSK3 expression appeared stable and the expression of FYN kinase was induced, by all the immunotherapies against the SKOV3 xenograft tumours, especially with combination therapy where the expression of β-TrCP was induced, which highlights another possible mechanism of controlling NRF2 levels and functions [87–89].